Notes on Living and Leaving,” explores the difficulties of having a celebrated director for a husband, and a celebrated ...

Lexicon Pharmaceuticals targets a turnaround with sotagliflozin, LX9851, pilavapadin, and partnerships offering multiple ...

The seven Colorado River states, including New Mexico, failed to reach a broad agreement Tuesday on how to share the river’s ...

Exact Sciences Corporation (EXAS) 7th Annual Healthcare Symposium November 14, 2025 8:50 AM ESTCompany ParticipantsDavid HardingConference ...

Ocugen’s consensus analyst price target has recently increased from $8.20 to $9.00, signaling a shift in market sentiment. This upward revision reflects greater confidence in the company’s growing ...

By combining clinical excellence with human understanding, Climbing Star stands out as more than a therapy provider — it’s a partner in helping families navigate the autism journey with clarity and ...

Q3 2025 Earnings Call Transcript November 14, 2025 MiNK Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Lihi Lapid is a best-selling Israeli novelist and author of an essay collection and children’s books, as well as a journalist ...

The Radio 2 presenter has raised over £9.5m carrying Pudsey Bear from near the Scottish border to Pudsey in Yorkshire this ...

"Within two days at the hospital, by day three, they called my family to come and say goodbye," she tells PEOPLE ...

Company plans new, confirmatory Phase 3 clinical trial of LYR-210 for treatment of chronic rhinosinusitis (CRS) without nasal polyps, on path to NDA submission – WATERTOWN, Mass., Nov. 12, 2025 (GLOBE ...

Immunovant remains on track for the first of the two batoclimab Phase 3 thyroid eye disease (TED) studies to read out before the end of calendar year 2025. However, due to evolving competitive ...